Exchange: NASDAQ·Updated 12:16 PM EDT
COGT logo

COGT Cogent Biosciences Inc

$30.35
$0.65
(2.10%)
Today
EarningsNov 3
Mkt Cap$5.38B
Vol762,898.00

About COGT

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation and other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.
33

Bearish Sentiment

How do you feel about COGT?

JFais
$COGT down to $30, good example of high-quality names that get thrown out with the bathwater (or at least dragged down)
1
mktrdr59
$COGT three wave measured move pullback to the Fib .382 retracement level, with bullish divergences on the technical indicators

Advertisement|Remove ads.